Milan, Italy

Brian Brown

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Fondazione Telethon, Ospedale San Raffaele S.r.l., Fondazione Centro San Raffaele Del Monte Tabor. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Brown. Retrieved from https://idiyas.com/inventor/brian-brown-bf7kbjy6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brian Brown: Innovator in Gene Vector Technology

Introduction

Brian Brown is a notable inventor based in Milan, Italy. He has made significant contributions to the field of gene vector technology, holding a total of 3 patents. His work focuses on advancing genetic research and therapeutic applications.

Latest Patents

Among his latest patents, Brian has developed a gene vector comprising a miRNA sequence target. This innovative approach aims to enhance the delivery and efficacy of genetic material in various applications. His contributions in this area are paving the way for future advancements in gene therapy.

Career Highlights

Throughout his career, Brian has worked with esteemed organizations such as Fondazione Telethon and Ospedale San Raffaele S.r.l. These institutions are known for their commitment to medical research and innovation, providing a solid foundation for his work in gene vectors.

Collaborations

Brian has collaborated with Luigi Naldini, a prominent figure in the field of gene therapy. Their partnership has led to significant advancements in the understanding and application of gene vectors.

Conclusion

Brian Brown's innovative work in gene vector technology and his collaborations with leading researchers highlight his impact on the field. His contributions are essential for the future of genetic research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…